Overview
Piracetam is a nootropic agent used primarily for cognitive enhancement and treatment of cognitive disorders. It is a cyclic derivative of GABA (gamma-aminobutyric acid) but does not act directly on GABA receptors. While used in many countries for conditions like cognitive impairment, dementia, and myoclonus, it is not FDA-approved in the United States.
Mechanism of Action
The exact mechanism of action is not fully understood. Piracetam is thought to enhance neuronal and vascular functions by increasing membrane fluidity, improving cerebral microcirculation, and modulating neurotransmitter systems (particularly acetylcholine and glutamate). It may also enhance neuroplasticity and protect against hypoxia.
Indications
- Cognitive impairment (e.g., in aging, dementia)
- Cortical myoclonus
- Dyslexia and learning disorders in children (off-label)
- Vertigo and dizziness associated with cerebrovascular insufficiency
- Sickle cell anemia (to reduce vaso-occlusive crises in some regions)
Dosage
Adults: Typically 1.2–4.8 g/day in 2–3 divided doses, depending on indication. For myoclonus: up to 20 g/day. Elderly: Lower doses may be used. Duration and dosing should be individualized based on response and tolerance.
Contraindications
- Hypersensitivity to piracetam or excipients
- Severe renal impairment (creatinine clearance <20 mL/min)
- Huntington's chorea (may exacerbate symptoms)
- Hemorrhagic stroke (acute phase)
- Pregnancy and lactation (unless clearly needed)
Side Effects
- Nervousness, anxiety, insomnia
- Dizziness, headache, drowsiness
- Gastrointestinal disturbances (nausea, diarrhea, abdominal pain)
- Weight gain
- Hyperkinesia (in children)
- Rash, pruritus
- Rare: thrombophlebitis, depression, confusion
Interactions
- May enhance effects of anticoagulants (e.g., warfarin) and antiplatelet drugs, increasing bleeding risk.
- Can potentiate effects of stimulants (e.g., amphetamines) and thyroid hormones.
- No significant interactions with common CYP450 substrates reported.